Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clinical Edge

Executive Summary

Brief summaries of recent advances in device research and clinical trials, including new evidence of the benefits of herniated disc surgery for older patients; the increase in the incidence of knee osteoarthritis; molecular breast imaging to detect breast cancer; the safety of endarterectomy for high-risk patients; and a new NIH grant program for innovative research.

You may also be interested in...



Is Spine Surgery Under Assault?

A recent article published in JAMA has spine surgeons crying foul. The article contends that spending on spine care increased 65% between 1997 and 2005--no big surprise given that healthc are spending in general increased by a similar amount over the same period. But an aggressive PR campaign behind the article seemed to single out surgery as a prime culprit in the rising costs and carried a clear message: that we're spending a lot on spine surgery and getting little in return. Moreover, claim surgeons, the article is just the latest in what they see as a larger campaing to cast doubts on the value of spine surgery and deny care to patients.

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035202

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel